Christina Ackermann - 06 Nov 2024 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Director
Signature
/s/ Andrew Fisher, Attorney-in-fact for Christina Ackermann
Issuer symbol
VRNA
Transactions as of
06 Nov 2024
Net transactions value
+$198,386
Form type
4
Filing time
07 Nov 2024, 18:56:12 UTC
Previous filing
30 Apr 2024
Next filing
29 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Purchase $198,386 +41,880 $4.74 41,880 06 Nov 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Consists of 41,880 Ordinary Shares represented by 5,235 ADSs.